Cervical and Breast Cancer

Screening

Sophia K. Apple MD
Director of Women’s Health & Breast Pathology
UCLA Medical Center
USA
Dr. George Nicolas Papanicolaou

1883-1962

In 1960, it was estimated by the

American Cancer Society that at
least 6 million women in the United
States alone had received the Pap
test. As a consequence of this
monumental discovery of the Pap
smear, deaths in women from
cancer of the cervix have been
reduced by at least 70 percent.

This test is a single most

successful discovery in medical
history. Sensitivity and specificity
outnumbers any other tests in
medicine.
 Summary recommendations on who should get
cervical screening test

• Should begin at age 21

• Q2 yrs for 21-29 yrs
• Q1 yr for >30 yrs for 3 consecutive yrs
• women c HIV: 2x/yr for the 1st yr, and Q1
• women c h/x of HG CIN or cancer: Q1/yr for the
next 20 yrs
• Age >65 with negative hx: discontinue
• s/p hysterectomy s HG CIN: discontinue
• s/p hysterectomy c HG CIN: continue even p
postmenopausal surveillance
• www.asccp.org
Conventional Pap Liquid Based Pap smears

20 yrs

Liquid-Based Pap (SurePath or ThinPrep)

Automated Image assisted Pap
HPV testing
HPV Vaccine: HPV 16 (54%) + HPV 18 (13%)
 Breast screening
American Cancer Society (ACS)
• Yearly mammograms are recommended starting at age 40
and continuing for as long as a woman is in good health
• Clinical breast exam (CBE) about every 3 years for women
in their 20s and 30s and every year for women 40 and over
• The American Cancer Society recommends that some
women - because of their family history, a genetic tendency,
or certain other factors - be screened with MRI in addition to
mammograms. (The number of women who fall into this
category is small: less than 2% of all the women in the US.)
 Imaging modalities

Ultrasound:
Cyst MRI:
Mass Mass
Mammogram: Architectural distortion Enhancing lesions
Calcifications Architectural distortion
Mass
Architectural distortion
 Pathology Requisition
201-68-22
Patient ID number: ______________ Date _ 4/15/07___
Jones
Last Name_______________First Mary Age 43
Bassett
Requesting physician: ______________________ 04203
ID ____________
Smith
Referring physician: ______________________ 01868
ID ____________
(310 206-9611)
R L

X X

Abnormality: Mass Calcifications √ Other

Imaging final assessment: 2 3 4A 4B 4C 5

Biopsy specimens contain calcifications

(Placed in bag in specimen container)
√
Comments:
Most likely DCIS
Tea bag contains calcifications. All cals removed via
Mammatome bx
 Screening Mammogram: abnormality

• Do Core Needle biopsy for pathology diagnosis

• No incisional bx necessary
• Wire localization of abnormal area
• Do lumpectomy for DCIS, T1 and T2 tumors
• Do mastectomy for larger /multifocal/multicentric tumors
– No frozen sections for diagnosis or margins
– Plan for multidisciplinary conference
 Multidisciplinary breast conference group

• Surgical oncologists
• Pathologists
• Oncologists
• Radiologists
• Radiology oncologists
• Psychosocial group

• Weekly conference to discuss all patients with DCIS or

Cancer.